Citadel Advisors’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-7,500
Closed -$178K 9124
2015
Q4
$178K Sell
7,500
-1,500
-17% -$34.9K ﹤0.01% 5953
2015
Q3
$180K Buy
9,000
+7,100
+374% +$142K ﹤0.01% 6289
2015
Q2
$37K Buy
1,900
+1,800
+1,800% +$37.3K ﹤0.01% 7866
2015
Q1
$2K Sell
100
-1,600
-94% -$36.7K ﹤0.01% 8442
2014
Q4
$37K Buy
1,700
+700
+70% +$14.9K ﹤0.01% 7424
2014
Q3
$20K Buy
1,000
+700
+233% +$15.2K ﹤0.01% 7451
2014
Q2
$7K Buy
+300
New +$6.37K ﹤0.01% 7687
2014
Q1
Sell
-100
Closed -$2K 8196
2013
Q4
$2K Sell
100
-2,400
-96% -$45.5K ﹤0.01% 6925
2013
Q3
$46K Buy
2,500
+1,800
+257% +$35.3K ﹤0.01% 5839
2013
Q2
$14K Buy
+700
New +$15.1K ﹤0.01% 6162

Other funds holding BMR

Citadel Advisors's BMR Position: Q1 2016 in Review

Citadel Advisors sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 4,149 shares — an estimated $98K sold.

Citadel Advisors first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $9.22M in Q4 2014. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Citadel Advisors reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Citadel Advisors sold 4,149 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $98K.
  • Citadel Advisors first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Citadel Advisors's BIOMED REALTY TRUST INC position peaked at $9.22M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.